XTX Topco Ltd
- SEC CIK
- 0001828301
- Latest filing
- Aug 14, 2026
NGM holding history
NGM Biopharmaceuticals Inc in every 13F filed by XTX Topco Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NGM overviewAll 13F holders of NGMFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −26,022−100.0% | Sold out | Holders |
| Q1 2024 | 26,022 | $41.4K | <0.1% | −2,954−10.2% | Reduced | Holders |
| Q4 2023 | 28,976 | $24.9K | <0.1% | −6,639−18.6% | Reduced | Holders |
| Q3 2023 | 35,615 | $38.1K | <0.1% | −7,830−18.0% | Reduced | Holders |
| Q2 2023 | 43,445 | $112.5K | <0.1% | −18,067−29.4% | Reduced | Holders |
| Q1 2023 | 61,512 | $251.0K | 0.1% | +61,512 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −34,571−100.0% | Sold out | Holders |
| Q2 2022 | 34,571 | $443.0K | 0.2% | +34,571 | New | Holders |